Table 1.
Clinical characteristics of the 12 study subjects
| Clinical characteristics | Nonischemic | Ischemic |
|---|---|---|
| Patients | 6 | 6 |
| Mean age (range), years** | 42 (27–60) | 59 (50–65) |
| Female sex | 1 | 1 |
| RV dysfunction | 2 | 6 |
| Pulmonary hypertension | 1 | 1 |
| Diabetes | 2 | 5 |
| ACEI/ARB | 4 | 4 |
| Beta blocker | 6 | 5 |
| Aldactone | 5 | 5 |
| Sildenafil | 1 | 2 |
| RA, mean (range), mmHg | 10 (1–17) | 9 (2–23) |
| PA, mean (range), mmHg | 28 (18–37) | 31 (13–47) |
| PCW, mean (range), mmHg | 18 (7–26) | 19 (4–25) |
| PVR, mean (range), Wood units | 2.5 (1.2–3.1) | 3.6 (2.3–6.7) |
| CI, mean (range) | 2.2 (1.7–2.7) | 2.1 (1.7–2.9) |
| IABP | 0 | 3 |
Note
Data are no. of patients, unless otherwise noted. ACEI: angiotensin-converting enzyme inhibitor; ARB: angiotensin receptor blocker; CI: cardiac index; IABP: intra-aortic balloon pump; PA: pulmonary artery pressure; PCW: pulmonary capillary wedge pressure; PVR: pulmonary vascular resistance; RA: right atrial pressure; RV: right ventricle.
**
P < 0.01.